Over the last 12 months, three Beneficient company insiders added shares at market prices, about $35,000 in total, and none of them sold.
The largest purchase came from CANGANY PETER T JR (Director), about $20,000. C-suite participation is part of the picture here.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters. Big money check: 19 institutions held BENF as of Q2 2026, and funds were split between buying and selling.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | CANGANY PETER T JR | Director | Buy | 18,868 | $1.06 | $20K | SEC |
| Sep 17, 2026 | Fletcher Derek L. | Officer | Buy | 4,717 | $1.06 | $5K | SEC |
| Sep 17, 2026 | Silk James G. | CEO | Buy | 9,434 | $1.06 | $10K | SEC |
| Mar 4, 2025 | Welday Jeff | Officer | Sell | 442 | $0.41 | $181 | SEC |
| Mar 4, 2025 | Welday Jeff | Officer | Sell | 941 | $0.34 | $320 | SEC |
| Feb 27, 2025 | Welday Jeff | Officer | Sell | 238 | $0.41 | $98 | SEC |
| Feb 27, 2025 | Welday Jeff | Officer | Sell | 201 | $0.42 | $84 | SEC |
| Feb 27, 2025 | Welday Jeff | Officer | Sell | 408 | $0.42 | $171 | SEC |
| Feb 19, 2025 | Welday Jeff | Officer | Sell | 1,191 | $0.47 | $560 | SEC |
| Feb 19, 2025 | Welday Jeff | Officer | Sell | 272 | $0.55 | $150 | SEC |
| Feb 19, 2025 | Welday Jeff | Officer | Sell | 272 | $0.47 | $128 | SEC |
| Feb 13, 2025 | Welday Jeff | Officer | Sell | 2,586 | $0.67 | $2K | SEC |
| Feb 13, 2025 | Welday Jeff | Officer | Sell | 885 | $0.63 | $558 | SEC |
| Feb 13, 2025 | Welday Jeff | Officer | Sell | 510 | $0.53 | $270 | SEC |
| Feb 10, 2025 | Welday Jeff | Officer | Sell | 136 | $0.59 | $80 | SEC |
In the last 12 months Beneficient insiders made open-market purchases worth about $35,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in BENF was filed on 2026-09-17.
19 investment managers reported holding BENF in SEC Form 13F filings for Q2 2026.
No congressional trades in BENF were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).